检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:尹智炜[1] 陈志强[1] 张再康[1] 丁奇峰[1] 范焕芳[1] 方敬[1]
机构地区:[1]河北医科大学中西医结合研究所,河北050017
出 处:《北京中医药大学学报》2006年第5期324-327,共4页Journal of Beijing University of Traditional Chinese Medicine
基 金:河北省博士基金项目(No.03547015D)
摘 要:目的观察肾络通对5/6肾切除肾衰竭大鼠残余肾组织纤溶酶原激活物抑制物-1(PAI-1)蛋白表达的影响。方法5/6肾切除制备肾衰竭大鼠模型,随机分为假手术组、模型组、肾络通组和缬沙坦组,分别灌胃给药16周取材,应用蛋白质印迹法检测肾组织PAI-1蛋白的表达。结果模型组与假手术组相比,PAI-1蛋白的表达明显增高(P<0.01);肾络通组PAI-1蛋白表达较模型组显著降低(P<0.05),与缬沙坦组比较无明显差异。结论肾络通可下调慢性进展性纤维化肾组织PAI-1蛋白表达,改善纤溶系统的失衡,延缓5/6肾切除肾衰大鼠的病程进展。Objective To observe the influence of Shenluotong on the protein expression of plasminogen activator inhibitor 1 (PAI-1) in kidney remaining tissue in rats with kidney failure induced by 5/6 of nephrectomy, nehtod The rat model of kidney failure was established by 5/6 of nephrectomy and the sham-operation group, model group, Shenluotong group and Valsartan group were set up and treated orally respectively for 16 weeks. The expression of PAI-1 protein in kidney tissue were detected by Western blotting method in different groups. Result The expression of PAI-1 protein was increased significantly in the model group compared with that in the sham -operation group (P 〈0. 01 ), and that in the Shenluotong group was decreased significantly (P 〈 0. 05 ) without significant difference compared with that of the Valsartan group. Conclusion Shenluotong can down-regulate the expression of PAI-1 protein in kidney tissue of chronic developing fibrosis, relieve the unbalance of fibrinolysic system, and delay the development of rat kidney failure after 5/6 of nephrectomy.
关 键 词:肾络通 肾衰竭 纤溶酶原激活物抑制物 蛋白质印迹 大鼠
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.112